Product Launch

Cymbiotika just named co-founder Durana Elmi its creative and experiential chief. It’s more than a title—it’s a blueprint for the future of wellness.

HOPPR's Catalyst Program is arming global researchers with advanced tools, accelerating AI projects from cancer detection in Africa to risk prediction in the US.

AABB restarts a major Mexican gold drill program, but its true strategy lies in a hybrid model weaving physical mining with a controversial crypto empire.

The Japanese Soy Milk Exchange launches to introduce a new premium category. Can heritage, technology, and high protein win over U.S. consumers?

AI saves workers 11 hours a week, yet firms see little gain. A new report reveals how 'botsitting' and 'botshitting' are erasing AI's promised ROI.

As finance rushes to adopt AI, Macrobond's new Data Feed Service offers a critical ingredient: trusted, auditable macroeconomic data for enterprise workflows.

As college grads face underemployment, a new nonprofit is giving high schoolers paid entry into healthcare and maritime, redefining the path to success.

A new video AI from Bria processes clips with temporal awareness, eliminating flicker and setting a new standard for quality and speed in content creation.

Lattice unveils new tools to measure AI's qualitative impact on performance, challenging the industry to move beyond simple usage metrics and prove real ROI.

As businesses rush to advertise on ChatGPT, a critical question emerges: does it work? CallRail's new integration aims to answer that, giving SMBs the tools to measure ROI and compete in the new AI-driven landscape.

The Napa Valley Wine Train's Legacy Experience isn't just a tour; it's a meticulously engineered journey blending 19th-century rail history with 21st-century luxury.

DuPont now powers its US healthcare plants with 100% renewables, a key move in a carbon-heavy sector. But a look behind the certificates reveals a complex strategy.

evyAI is offering its full AI sales agent for free until summer 2026, challenging the subscription model. We dig into the strategy, the risks, and what it means for you.

As official Semiquincentennial plans face political division, a new independent website, Wisdomof250.com, aims to unite the nation’s celebrations.

The asset manager's May report reveals $3.3B in net inflows, driven by a major target date fund win, underscoring its market resilience and leadership.

A junior miner revives a historic Utah uranium district, blending old data with new tech. Is this a savvy play for the nuclear boom or a speculative gamble?

New clinical data suggests Cullinan Therapeutics' cancer-fighting tech could offer durable, treatment-free remission for severe RA and lupus patients.

Organon's FDA nod for TOFIDENCE in critical care isn't just a clinical win. It's a calculated move to capture market share and challenge high-cost biologics.

Latest drill results from Brunswick Exploration’s Anatacau project reveal major lithium potential, sparking comparisons to its flagship Mirage asset.

A Texas university is building a city-within-a-city. Is this a bold new model for institutional survival or a high-stakes gamble on real estate?